About

Substantial progress in the treatment of atherosclerotic complications – in particular in secondary prevention – has led to a significant reduction of recurrent cardiovascular events. This has been through the use of pharmacological strategies including lipid-lowering drugs such as statins, beta-blockers, angiotensin-converting ensyme inhibitors and angiotensin receptor blockers, along with the introduction of early percutaneous coronary intervention in acute coronary syndrome with consecutive application of dual antiplatelet therapy.

Articles

Intravascular Ultrasound-based Imaging Modalities for Tissue Characterisation

Citation:

Interventional Cardiology Review 2014;9(3):151–5

Characteristics of Adiponectin and Coronary Plaque - An Intravascular Ultrasound Study

Citation:

Interventional Cardiology 2008;3(1):30-2

The Adventitia - The New Frontier in Coronary Atherosclerosis Imaging

Citation:

Interventional Cardiology 2007;2(1):15-6

Plaque Vulnerability and Related Coronary Event Prediction by Virtual Histology

Citation:

Interventional Cardiology 2006;1(1):17-9